CXM Share Price

Open 0.79 Change Price %
High 0.81 1 Day -0.04 -5.00
Low 0.76 1 Week 0.00 0.00
Close 0.76 1 Month 0.00 0.00
Volume 98707 1 Year 0.00 0.00
52 Week High 10.15
52 Week Low 0.00
CXM Important Levels
Resistance 2 0.81
Resistance 1 0.79
Pivot 0.78
Support 1 0.73
Support 2 0.71
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
RBY 0.03 -70.00%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
NAK 1.46 -6.41%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
RVP 0.64 -51.15%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SARA 0.07 -22.22%
SNT 0.12 -20.00%
More..

Cardium Therapeutics, Inc. (AMEX: CXM)

CXM Technical Analysis 3
As on 23rd Jan 2014 CXM Share Price closed @ 0.76 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.52 & Buy for SHORT-TERM with Stoploss of 0.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
CXM Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Cardium Therapeutics, Inc. ( AMEX USA Symbol : CXM )
Sector : Health Care Biotechnology: Biological Products (No Diagnostic Substances) And Other Stocks in Same Sector
CXM
0.76 -0.04 (-5.00 %)
LT : Buy
ST : Buy
CXM Other Details
Segment EQ
Market Capital 22787106.00
Sector Health Care Biotechnology: Biological Products (No Diagnostic Substances)
Industry
Offical website
CXM Address
CXM
N/A
CXM Latest News
Is TAXUS CARDIUM PHARMA (OTCMKTS:CRXM)'s Fuel Running Low? Reports Show More ...   WeeklyHub   - 31st Jul 17
Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance ...   PR Newswire (press release)   - 12th Sep 16
Angionetics Presents at the 2015 American Society of Gene & Cell Therapy ...   PR Newswire (press release)   - 15th May 15
Taxus Cardium Announces Agreement With Dr. Reddy's Laboratories To Co-Develop ...   PR Newswire (press release)   - 07th Apr 15
Taxus Cardium Announces Biological and Clinical Advances in Angiogenic Gene ...   Business Wire (press release)   - 13th Aug 14
Cardium Announces Positive Interim Phase 3 Clinical Data Showing Significant ...   PR Newswire (press release)   - 24th Jun 14
Taxus Cardium's Excellagen® Selected For Use With Stem Cells In European Union ...   PR Newswire (press release)   - 12th May 14
Cardium Becomes Taxus Cardium Pharmaceuticals Group In Connection With ...   PR Newswire (press release)   - 17th Mar 14
Cardium Announces Strategic Collaboration And Funding With Taxus ...   PR Newswire (press release)   - 03rd Mar 14
0.1631   MarketWatch   - 31st Jan 14
Interactive Technical Analysis Chart Cardium Therapeutics, Inc. ( CXM AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cardium Therapeutics, Inc.
CXM Business Profile
N/A